Inventor · disambiguated record
Sophie Hallakou-Bozec
Also filed as: HALLAKOU-BOZEC SOPHIE
16 granted patents·4 pending applications·53 citations·filing 2006–2025
91Inventor score
Top patents by PatentIndex Score
20 records- 0189US8329698B2Quinoxalinedione derivatives which are activators of AMPK-activated protein kinaseCRAVO DANIEL·Filed 2009·Granted Dec 11, 2012·12 cites·2 claims
- 0287US8674097B2Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinaseCRAVO DANIEL·Filed 2012·Granted Mar 18, 2014·11 cites·5 claims
- 0382US9035048B2Tetrahydrotriazine compounds for treating diseases associated with AMPK activityCRAVO DANIEL·Filed 2009·Granted May 19, 2015·6 cites·4 claims
- 0480US9895380B2Methods and pharmaceutical compositions for the treatment of hepatitis B virus infectionINST NAT SANTE RECH MED·Filed 2014·Granted Feb 20, 2018·5 cites·9 claims
- 0575US9284329B2Thienopyridone derivatives useful as activators of AMPKPOXEL·Filed 2013·Granted Mar 15, 2016·4 cites·10 claims
- 0675US8563729B2Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activatorsCRAVO DANIEL·Filed 2009·Granted Oct 22, 2013·2 cites·14 claims
- 0774US9271984B2Treatment of type 1 diabetesFOUQUERAY PASCALE·Filed 2011·Granted Mar 1, 2016·6 cites·5 claims
- 0874US8604202B2Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activatorsCRAVO DANIEL·Filed 2009·Granted Dec 10, 2013·2 cites·15 claims
- 0974US8470849B27-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitorsCARNIATO DENIS·Filed 2008·Granted Jun 25, 2013·2 cites·11 claims
- 1072US8329738B2Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising themMOINET GERARD·Filed 2007·Granted Dec 11, 2012·2 cites·15 claims
- 1165US9365584B2Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereofCRAVO DANIEL·Filed 2010·Granted Jun 14, 2016·1 cites·13 claims
- 1260US11617754B2Methods of treating heart failure with preserved ejection fractionPOXEL SA·Filed 2018·Granted Apr 4, 2023·0 cites·22 claims
- 1359US11850238B2Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathyPOXEL·Filed 2021·Granted Dec 26, 2023·0 cites·19 claims
- 1457US12310949B2Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)POXEL·Filed 2021·Granted May 27, 2025·0 cites·6 claims
- 1553US12319700B2Monohydrate potassium salt of a thienopyridone derivative and its preparation processPOXEL·Filed 2019·Granted Jun 3, 2025·0 cites·18 claims
- 1653US10071108B2Methods and pharmaceutical compositions for the treatment of hepatitis b virus infectionINST NAT SANTE RECH MED·Filed 2018·Granted Sep 11, 2018·0 cites·16 claims
- 1752US2025154164A1Monohydrate potassium salt of a thienopyridone derivative and its preparation processPOXEL·Filed 2025·Application pending·0 cites
- 1850US2023149370A1Use of a thienopyridone derivative in the treatment of diabetic nephropathyPOXEL·Filed 2021·Application pending·0 cites
- 1941US2009105293A1Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing themHALLAKOU-BOZEC SOPHIE·Filed 2006·Application pending·0 cites
- 2031US2013131065A1Treatment of type 2 diabetesFOUQUERAY PASCALE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →